Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nature Methods|May 17, 2011
A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteinsShivendra Kishore, Lukasz Jaskiewicz, Lukas Burger, et al.
Plos One|September 9, 2008
Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory systemAlessia Galgano, Michael Forrer, Lukasz Jaskiewicz, et al.
EMBO Reports|September 6, 2005
TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencingAstrid D Haase, Lukasz Jaskiewicz, Haidi Zhang, et al.
Genome Research|March 27, 2014
Widespread context dependency of microRNA-mediated regulationFlorian Erhard, Jürgen Haas, Diana Lieber, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2006
The chromatoid body of male germ cells: similarity with processing bodies and presence of Dicer and microRNA pathway componentsNoora Kotaja, Suvendra N Bhattacharyya, Lukasz Jaskiewicz, et al.
Molecular Systems Biology|December 5, 2013
Timescales and bottlenecks in miRNA-dependent gene regulationJean Hausser, Afzal Pasha Syed, Nathalie Selevsek, et al.
RNA (New York, N.Y.)|July 25, 2013
The double-stranded RNA binding domain of human Dicer functions as a nuclear localization signalMichael Doyle, Lukas Badertscher, Lukasz Jaskiewicz, et al.
Pharmacoepidemiology and Drug Safety|July 16, 2015
Aggregate analysis of regulatory authority assessors' comments to improve the quality of periodic safety update reportsSandra Jullian, Lukasz Jaskiewicz, Hans-Jürgen Pfannkuche, et al.
International Journal of Molecular Sciences|October 19, 2019
Pituitary Hormones (FSH, LH, PRL, and GH) Differentially Regulate AQP5 Expression in Porcine Ovarian Follicular CellsMariusz T Skowronski, Patrycja Mlotkowska, Damian Tanski, et al.
Expert Opinion on Investigational Drugs|May 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (70 mg/mL) in healthy male adultsMonika Tomaszewska-Kiecana, Felicitas Bullo, Lukasz Jaskiewicz, et al.
Pageof 3